Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Luis E, Morano Amado"'
Autor:
José Miguel Dávila Martín, Juan A. Pineda, Luis E. Morano-Amado, E N Álvarez, Montserrat Pérez-Pérez, R Sarmento E Castro, Juan Macías, Ris-Hep study groups, M.J. Ríos, M J Álvarez-Ossorio, J Mendez, Dolores Merino, Rafael Granados, Francisco Téllez, Karin Neukam, Antonio Collado, Hepavir-Daa, Gehep-Mono, Ris-Hep
Publikováno v:
Journal of Viral Hepatitis. 25:699-706
Little data are available on renal toxicity exerted by direct-acting antivirals (DAAs) in real life. The aim of this study was to assess the impact of direct-acting antivirals against hepatitis C virus infection currently used in Spain and Portugal o
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 107, Iss 4, Pp 251-251 (2015)
Externí odkaz:
https://doaj.org/article/e0870c8449b54300af211ae99b219fcd
Autor:
Montserrat Pérez-Pérez, Rosario Palacios, Antonio Rivero-Juárez, Antonio Rivero, Maria Rios, Luis E. Morano-Amado, Juan A. Pineda, María Mancebo, Juan Macías, Francisco Téllez, Dolores Merino, Antonio Collado, Ana Belén Pérez, Ignacio Santos
Publikováno v:
HIV clinical trials. 19(1)
Background Data on the efficacy, safety, and concomitant use with other drugs of the combination ritonavir-boosted paritaprevir/ombitasvir plus dasabuvir (PrOD) in HIV/HCV-coinfected patients in real life are limited. The objectives of this study wer
Autor:
Marta Montero-Alonso, Maria Rios, Sergio Reus-Bañuls, Luis E. Morano-Amado, Paloma Geijo-Martínez, Francisco Téllez, Karin Neukam, Antonio Collado, Francisco Jesús Vera-Méndez, Ignacio de los Santos-Gil, Marta Suárez-Santamaría, Juan A. Pineda, María Mancebo, Antonio Rivero-Juárez, Rafael Granados
Publikováno v:
HIV CLINICAL TRIALS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Objective: HIV/HCV-coinfected patients and hepatitis C virus (HCV) monoinfected subjects are thought to respond equally to direct-acting antiviral (DAA)-based therapy despite the lack of data derived from clinical trials. This study is aimed to evalu
Autor:
M.J. Ríos, Francisco Téllez, Karin Neukam, Luis E. Morano-Amado, E. Nuño-Álvarez, Antonio Rivero-Juárez, Juan Macías, Montserrat Pérez-Pérez, Dolores Merino, Juan A. Pineda
Publikováno v:
Journal of Hepatology. 66:S526-S527
Publikováno v:
Medicina clinica. 129(17)